PharmAthene Cash from Operations Quarterly:
-2.145M for Dec. 31, 2012PharmAthene Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -2.145M |
| Sept. 30, 2012 | 1.734M |
| June 30, 2012 | -2.704M |
| March 31, 2012 | 0.7914M |
| Dec. 31, 2011 | -0.8051M |
| Sept. 30, 2011 | -3.618M |
| June 30, 2011 | -1.298M |
| March 31, 2011 | -2.087M |
| Dec. 31, 2010 | -6.718M |
| Sept. 30, 2010 | -1.562M |
| June 30, 2010 | -2.203M |
| March 31, 2010 | -4.382M |
| Dec. 31, 2009 | -6.183M |
| Sept. 30, 2009 | -8.545M |
| June 30, 2009 | -6.646M |
| March 31, 2009 | -6.772M |
| Dec. 31, 2008 | -3.823M |
| Sept. 30, 2008 | -5.286M |
| June 30, 2008 | 1.184M |
| March 31, 2008 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
PIP Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Emergent BioSolutions | -4.626M |
| BioTime | -4.996M |
| Savient Pharmaceuticals | -20.15M |
PIP Cash from Operations Quarterly Rankings
| Overall |
53rd percentile 3735 of 8002 |
| Sector |
47th percentile 358 of 684 in Healthcare |
| Industry |
64th percentile 87 of 248 in Biotechnology |
PIP Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -8.545M | Sep 2009 |
| Maximum | 1.735M | Sep 2012 |
| Average | -3.214M |
